NDAORALTABLET, CHEWABLE
Approved
Dec 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
5/8 — Partial
CHILDREN'S ADVIL (ibuprofen) by GSK is cyclooxygenase inhibitors [moa]. Approved for pain, fever, headache and 4 more indications. First approved in 1998.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Children's Advil is an oral, chewable tablet formulation of ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase enzymes to reduce pain and fever. It is indicated for pain relief, fever reduction, and treatment of conditions including headache, sore throat pain, osteoarthritis, back pain, and postoperative pain in pediatric and adult populations.
LOE Approaching
Product is in late-stage lifecycle with LOE approaching, indicating a mature brand facing competitive and generic pressures that will require strategic repositioning or portfolio transition planning.
Worked on CHILDREN'S ADVIL at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.